HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carlos Ugrinowitsch Selected Research

Resistance Training

5/2022Resistance training variable manipulations are less relevant than intrinsic biology in affecting muscle fiber hypertrophy.
4/2022Muscle Hypertrophy Response Is Affected by Previous Resistance Training Volume in Trained Individuals.
1/2022Effects of Blood Flow Restriction Combined With Resistance Training or Neuromuscular Electrostimulation on Muscle Cross-Sectional Area.
1/2021Effects of resistance training on metabolic and cardiovascular responses to a maximal cardiopulmonary exercise test in Parkinson`s disease.
9/2019Effect of individualized resistance training prescription with heart rate variability on individual muscle hypertrophy and strength responses.
4/2019Individual Muscle Hypertrophy and Strength Responses to High vs. Low Resistance Training Frequencies.
1/2019Short-term resistance training with instability reduces impairment in V wave and H reflex in individuals with Parkinson's disease.
1/2019Myofibrillar protein synthesis and muscle hypertrophy individualized responses to systematically changing resistance training variables in trained young men.
9/2018High-frequency resistance training does not promote greater muscular adaptations compared to low frequencies in young untrained men.
7/2018Effects of different intensities of resistance training with equated volume load on muscle strength and hypertrophy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carlos Ugrinowitsch Research Topics

Disease

17Hypertrophy
05/2022 - 03/2012
9Parkinson Disease (Parkinson's Disease)
01/2022 - 01/2016
3Breast Neoplasms (Breast Cancer)
01/2022 - 08/2020
3Fatigue
01/2021 - 01/2011
2Pain (Aches)
01/2022 - 09/2019
2Neoplasms (Cancer)
12/2021 - 01/2021
2Edema (Dropsy)
01/2019 - 01/2016
2Inflammation (Inflammations)
12/2018 - 02/2010
2Myalgia
08/2010 - 03/2009
1Body Weight (Weight, Body)
10/2021
1COVID-19
01/2021
1Sleep Deprivation
01/2020
1Heart Failure
07/2016
1Atrophy
07/2016
1Multiple System Atrophy
09/2014
1Stroke (Strokes)
10/2013
1Myositis (Idiopathic Inflammatory Myopathies)
06/2010
1Disease Progression
06/2010
1Inclusion Body Myositis
02/2010

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
10/2021 - 06/2015
3Muscle Proteins (Muscle Protein)IBA
03/2018 - 09/2014
2Messenger RNA (mRNA)IBA
09/2014 - 03/2012
2Creatine Kinase (Creatine Phosphokinase)IBA
08/2010 - 03/2009
1MicroRNAs (MicroRNA)IBA
01/2022
1Leucine (L-Leucine)FDA Link
10/2021
1SuspensionsIBA
01/2021
1COVID-19 VaccinesIBA
01/2021
1Hormones (Hormone)IBA
01/2020
1CytokinesIBA
01/2020
1deoxyhemoglobinIBA
01/2019
1MouthwashesIBA
12/2018
1CarbohydratesIBA
12/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
12/2018
1E 10 (E-10)IBA
01/2018
1SteroidsIBA
01/2018
1beta-Aminoethyl Isothiourea (AET)IBA
07/2016
1Insulin-Like Growth Factor I (IGF-1)IBA
07/2016
1Deuterium Oxide (Heavy Water)IBA
01/2016
1N-(2-acetamido)-2-aminoethanesulfonic acid (ACES)IBA
10/2013
1MyostatinIBA
03/2012
1Lactic Acid (Lactate)FDA LinkGeneric
01/2011
1Immunomodulating AgentsIBA
06/2010
1Interleukin-6 (Interleukin 6)IBA
03/2009
1InterleukinsIBA
03/2009
1Prostaglandins EIBA
03/2009
1ProstaglandinsIBA
03/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009

Therapy/Procedure

26Resistance Training
05/2022 - 02/2010
2Endurance Training
01/2022 - 01/2018
2Drug Therapy (Chemotherapy)
12/2021 - 08/2020
1Radiotherapy
12/2021
1Blood Flow Restriction Therapy
09/2019
1Activities of Daily Living (ADL)
09/2014